Show simple item record

dc.contributor.authorAliasgharlou, L
dc.contributor.authorGhanbarzadeh, S
dc.contributor.authorAzimi, H
dc.contributor.authorZarrintan, MH
dc.contributor.authorHamishehkar, H
dc.date.accessioned2018-08-26T07:23:14Z
dc.date.available2018-08-26T07:23:14Z
dc.date.issued2016
dc.identifier.urihttp://dspace.tbzmed.ac.ir:8080/xmlui/handle/123456789/46387
dc.description.abstractPurpose: Hyperpigmentation occurs when melanin is overproduced in certain spots on the skin and is one of the most challenging skin conditions to treat. Although it is usually harmless, for cosmetic reasons, it is dreadfully bothersome to those who undergo it. It was reported that N-acetyl-glucosamine ( NAGA) prevents melanin synthesis and alters the expression of numerous genes related to pigmentation. In spite of these advantages, NAGA cannot be employed in topical formulations due to its extremely polar characteristics. Nanoparticles, especially lipid-based ones, have been introduced as an efficient carrier for dermal drug delivery. Methods: The aim of the present study was to load adequate hydrophilic NAGA to the lipophilic nanostructured lipid carriers ( NLCs) for potential dermal application. Methods: NAGA-loaded NLCs were formulated, using hot homogenization technique, and the characteristics of the optimized formulation were analyzed by laser light scattering, X-ray diffraction, and scanning electron microscopy methods. Loading capacity percentage and in vitro release study were carried out by applying a validated HPLC method. The optimum formulation was utilized for the in vivo skin lightening evaluations in healthy volunteers. Results: NAGA-loaded NLCs demonstrated promising results ( the size of 190 nm, narrow size distribution, loading capacity of 9%, and appropriate NAGA release profile) suitable for dermal delivery. XRD results exhibited a dramatic reduction in the crystalline structure of encapsulated NAGA. Dermoscopy images indicated a considerable decline in melanin distribution pattern in the majority of the cases treated with NAGA-loaded NLCs. Conclusion: Thus, this study has opened new horizons for the potential use of lipid based nanoparticles in the managing of hyperpigmentation.
dc.language.isoEnglish
dc.relation.ispartofADVANCED PHARMACEUTICAL BULLETIN
dc.subjectNanostructured Lipid Carriers
dc.subjectNLCs
dc.subjectN-acetyl glucosamine
dc.subjectDermal delivery
dc.subjectHyperpigmentation
dc.titleNanostructured Lipid Carrier for Topical Application of N-Acetyl Glucosamine
dc.typeArticle
dc.citation.volume6
dc.citation.issue4
dc.citation.spage581
dc.citation.epage587
dc.citation.indexWeb of science
dc.identifier.DOIhttps://doi.org/10.15171/apb.2016.072


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record